A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer. - Zhou, Mingzhen; Jin, Yuncheng; Zhu, Sihui; Xu, Chen; Li, Lin; Liu, Baorui; Shen, Jie (Clinical & Translational Immunology, 2024)